Slil Biomedical Corporation
Records under this name other than patents Slil Biomedical Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Slil Biomedical Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,794,545 | Conformationally restricted polyamine analogs as disease therapies Formerly held Lapsed on the fee record Ended Sep 21, 2016 · USPTO record | Lapsed on the fee record | Ended Sep 21, 2016 | USPTO record |
| US 6,649,587 | Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases Formerly held Lapsed on the fee record Ended Nov 18, 2015 · USPTO record | Lapsed on the fee record | Ended Nov 18, 2015 | USPTO record |
| US 7,279,502 | Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases Formerly held Lapsed on the fee record Ended Oct 9, 2015 · USPTO record | Lapsed on the fee record | Ended Oct 9, 2015 | USPTO record |
| US 7,186,825 | Conformationally restricted polyamine analogs as disease therapies Formerly held Lapsed on the fee record Ended Mar 6, 2015 · USPTO record | Lapsed on the fee record | Ended Mar 6, 2015 | USPTO record |
| US 7,026,347 | Porphyrin-polyamine conjugates for cancer therapy Formerly held Lapsed on the fee record Ended Apr 11, 2014 · USPTO record | Lapsed on the fee record | Ended Apr 11, 2014 | USPTO record |
| US 6,982,351 | Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor Formerly held Lapsed on the fee record Ended Jan 3, 2014 · USPTO record | Lapsed on the fee record | Ended Jan 3, 2014 | USPTO record |
| US 7,491,849 | Oligoamine compounds and derivatives thereof for cancer therapy Formerly held Lapsed on the fee record Ended Feb 17, 2013 · USPTO record | Lapsed on the fee record | Ended Feb 17, 2013 | USPTO record |
| US 7,453,011 | Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor Formerly held Lapsed on the fee record Ended Nov 18, 2012 · USPTO record | Lapsed on the fee record | Ended Nov 18, 2012 | USPTO record |
| US 6,809,176 | Quinones as disease therapies Formerly held Lapsed on the fee record Ended Oct 26, 2012 · USPTO record | Lapsed on the fee record | Ended Oct 26, 2012 | USPTO record |
| US 7,312,244 | Polyamine analog-amino acid conjugates useful as anticancer agents Formerly held Lapsed on the fee record Ended Dec 25, 2011 · USPTO record | Lapsed on the fee record | Ended Dec 25, 2011 | USPTO record |